PROTAGONIST THERAPEUTICS INC
PTGXNASDAQ🏆 #790 by market capEarnings Nov 5US Equity
$148.29▼ $1.69 (−1.14%)
Pre-market · at close1h—
24h▼ 1.1%
7d▲ 7.8%
14d▲ 11.7%
30d▲ 14.3%
1y▲ 172.0%
🏦Market Cap
$9.54B
Small Cap
📈Revenue Growth (YoY)
+34.8%
High Growth
📊Gross Margin
—
💵FCF Margin
77.6%
Strong
⚖️P/S Ratio
33.9x
Expensive
Otter Score
42
Weak
🔭
No analyst ratings for PTGX
We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.